September 19, 2019
Dicerna appoints Patrick Gray to Board of Directors
Dicerna has announced Retirement of Board of Director Veteran Dennis Langer, and to his place has named Patrick Gray.
pharmaceutical daily
Pharmaceuticals, Biotechnology and Life Sciences
September 19, 2019
Five Prime Therapeutics name new CEO
San Francisco based clinical-stage biotech company Five Prime Therapeutics has named the new interim Chief Executive Officer, William Ringo, who will start immediately, to replace Aron Knickerbocker, who has resigned to look for new opportunities.
September 19, 2019
Bristol-Myers Squibb show breadth of oncology development program and focus on improving overall survival across multiple cancers
Overall survival data from CheckMate -227 Part 1 evaluating Opdivo (nivolumab) plus low-dose Yervoy (ipilimumab) in advanced non-small cell lung cancer featured in ESMO Presidential Symposium
September 19, 2019
Citizens against government waste slams speaker Pelosi’s horrendous drug pricing bill
WASHINGTON–(BUSINESS WIRE)–#Medicare–Today, Citizens Against Government Waste (CAGW) released the following comments regarding House Speaker Nancy Pelosi’s (D-Calif.) partisan drug pricing…
September 19, 2019
Pfizer Presents Scientific Advancements in Cancer Care at the ESMO Congress 2019 Highlighting Expanded Portfolio
Presentations of interest include a late-breaking abstract on expanded Phase 3 data in BRAF-mutant metastatic colorectal cancer NEW YORK–(BUSINESS WIRE)–Pfizer…
September 19, 2019
Context Therapeutics and Jefferson Health to evaluate Apristor combination therapy for women with advanced endometrial cancer
Apristor, an oral progesterone receptor antagonist, is being studied in combination with an antiestrogen in advanced ER+,PR+,HER2- endometrial cancer Study…
September 19, 2019
Tetra Therapeutics Sees Rapid Patient Recruitment and Representative Patient Diversity in its PICASSO Phase 2 Alzheimer’s Disease Trial
Tetra Therapeutics has surpassed 50% enrollment – 65% of which are Hispanic patients– in its Phase 2 clinical trial (PICASSO…
September 19, 2019
Walgreens Boots Alliance schedules Fourth Quarter and Fiscal 2019 Earnings Announcement for October 28, 2019
DEERFIELD, Ill.–(BUSINESS WIRE)–Walgreens Boots Alliance, Inc. (Nasdaq: WBA) will release its fourth quarter and fiscal 2019 earnings results at 7…
September 19, 2019
The American Journal of Managed Care® Hosts ‘The Challenges and Treatment of Sickle Cell Disease’ Panel Discussion
The panel of experts consider the challenges of treating sickle cell disease and share insight on emerging therapeutic agents CRANBURY,…
September 19, 2019
Nebula Genomics Launches Anonymous Genetic Testing
Calls for adoption of privacy-preserving technologies by direct-to-consumer personal genomics companies SAN FRANCISCO & BOSTON–(BUSINESS WIRE)–Nebula Genomics, a privacy-focused personal…